Understanding chronic hives with no known cause: navigating unpredictable flare-ups of itch and hives
(BPT) - Key takeaways:
- Emily suddenly developed severe, itchy hives that impacted her throughout the day and night.
- Emily's dermatologist diagnosed her with chronic hives with no known cause, called chronic spontaneous urticaria (CSU).
- After her hives continued and weren't controlled with H1 antihistamine treatment, a prescription medicine helped Emily. The treatment works by targeting a key source of underlying inflammation that can contribute to CSU.
When Emily woke up one June morning in 2025 covered in hives, she was startled. Assuming she was having an allergic reaction, she tried to treat it with allergy medicines and topical creams, hoping the relentless itching would stop. After three days with no relief, Emily went to the hospital.
"The doctors had no idea what was wrong with me," she said. "They gave me a steroid pack and a shot and sent me home. I finished the pack, but there was no improvement. If anything, it spread."
Emily's regular doctor referred her to a dermatologist, who eventually diagnosed her with chronic spontaneous urticaria or CSU, for short.
Recognizing CSU symptoms
CSU often shows up as spontaneous itch and red or skin-colored bumps or hives that appear with no rhyme or reason. Also referred to as chronic hives with no known cause, CSU is chronic and leaves sufferers searching for answers, sometimes for years. Symptoms can include:
- Hives that are on and off over 6 weeks or more, sometimes with deeper swelling beneath the skin (commonly known as angioedema).
- Sudden episodes of hives or "flare-ups" that can last for days or even weeks.
These hives are known to appear, disappear, then appear on another area, such as the chest, back, arms or legs. "The hives initially appeared on my right torso area as a patch, but started moving to the left side, and up my back and then down to my legs," Emily said.
CSU is not an allergic reaction. Instead, it may be that the body's immune system is out of balance and could be the source of spontaneous flare-ups. This immune imbalance can be a driver of inflammation that contributes to the itch and hives patients experience.
Almost twice as many adult women are affected by CSU compared to men. While CSU can develop at any age, it most commonly affects women between ages 20 and 40, like Emily who first experienced symptoms at 36. For most adults, hives cases last between 2-5 years, though some patients experience symptoms for longer.
Daily life with CSU
CSU is especially challenging because flare-ups of itch and hives can happen without warning.
"The unpredictable nature of CSU is very disruptive," said Erin Xiaolu Barrett, MD, MBA, FAAD, practicing dermatologist, Professor and Chair, Department of Dermatology, University of Nebraska at Omaha. "It becomes challenging for people because they don't know when their condition will flare up. They could be at work and suddenly be covered in itchy hives."
The cause of CSU is unknown. However, certain factors such as stress and tight clothing may worsen symptoms during a flare-up and make everyday activities more challenging. For Emily, having CSU made it challenging to enjoy summers in Michigan where she normally spent most of her time outdoors playing with her German Shepherd, attending outdoor family gatherings, hiking and swimming in the lake.
"I couldn't be outside for a long period of time if it was too hot because I would begin to sweat and that would irritate my hives," Emily said. "After five minutes, I'd have to go inside."
"The hives started to spread to my arms and chest," she said. "My nieces and nephews would ask, 'What's going on?' and people would stare as if my hives and rashes were contagious."
Barriers to a CSU diagnosis
Getting a CSU diagnosis can take a long time. On average, patients spend 2 to 3 years seeking answers.
"I've had many patients with CSU who were repeatedly treated for scabies, bedbug bites and other external conditions," said Barrett. "And because many patients mistakenly believe they're having an allergic reaction to food or an environmental allergen, they'll change their diet or the lotions they use or hire exterminators, hoping the hives go away."
The good news: diagnosis doesn't require allergy testing or skin biopsy. Your doctor can diagnose CSU based on your symptoms and medical history alone, and many patients are helped by H1 antihistamines, which are allergy medicines.
H1 antihistamines, however, are not enough for more than 50% of adult CSU patients, even when taking more than the standard dose.

"I couldn't be outside for a long period of time if it were too hot because I would begin to sweat and irritate my hives," Emily said. "After five minutes, I'd have to go inside."

Another path to managing CSU: a difference you can see and feel
As Emily's symptoms remained uncontrolled despite H1 antihistamine treatment, her dermatologist recommended she try DUPIXENT® (dupilumab), an FDA-approved prescription medicine used to treat adults and children 2 years of age and older with CSU who continue to have hives that are not controlled with H1 antihistamine treatment. DUPIXENT is not used to treat any other forms of hives (urticaria).
Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT.
Please see additional safety information below.
Dupixent helps manage chronic hives with no known cause proactively by targeting a key source of inflammation inside your body. This can help to reduce the intense itching and the number of hives that make CSU disruptive. Dupixent works continuously between doses to help you get ahead of your symptoms.
Dupixent was studied in two 24-week clinical trials in 284 patients ages 12 years and older with CSU who continued to have hives despite taking H1 antihistamines. All patients remained on H1 antihistamines during the trials.
At 24 weeks, patients on Dupixent had less itch* (trial 1 showed 64% itch reduction with Dupixent vs 35% on placebo and trial 2 showed 48% itch reduction with Dupixent vs 33% on placebo). Patients also had a reduction in both itch and hives at week 24† (trial 1 demonstrated 66% reduction on Dupixent vs 36% on placebo and trial 2 showed 48% reduction on Dupixent vs 32% on placebo). Also, nearly twice as many patients had no itch and no hives at 24 weeks (trial 1 showed 32% on Dupixent vs 13% on placebo and trial 2 showed 30% on Dupixent vs 17% on placebo). Individual results may vary.
The most common side effects in CSU patients 12+ years of age include injection site reactions.
Dupixent's use for treating CSU in children ages 2-11 years is supported by the results from two studies that included patients 12 years of age and older with CSU.
After some time using Dupixent, the intensity of Emily's itching reduced, and her hives began to improve. With her symptoms under control, she thinks less about her hives and constant itching and feels more comfortable with her skin. While this was Emily's experience, others may have a different experience.
"I took a trip to the lake with my boyfriend, and I was able to focus more on what I was doing and less on my symptoms," she shared.
*Patients rated itch daily (from 0-3) for 7 days (max score 21), compared to baseline score.
†Patients also rated their hives daily (from 0-3) for 7 days (max score 21). This score was added to their itch severity score, compared to baseline score.
Speaking up for relief from CSU
Emily hopes her story inspires other patients experiencing CSU to speak up. "If you're struggling with CSU like I was, know this: you're not alone, your symptoms are valid, and there is hope," she said.
"Don't let anyone make you feel ashamed of your skin. I hope people also understand that CSU isn't a cosmetic issue but a real condition that can be challenging. With proper diagnosis and treatment, patients like me can potentially find relief from the itch and hives."
Talk to a dermatologist to discuss treatment options. To learn more about CSU and Dupixent (dupilumab), visit Dupixent.com.
IMPORTANT SAFETY INFORMATION & INDICATION
Do not useif you are allergic to dupilumab or to any of the ingredients in DUPIXENT®.
Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you:
- have eye problems.
- have a parasitic (helminth) infection.
- are scheduled to receive any vaccinations. You should not receive a "live vaccine" right before and during treatment with DUPIXENT.
- are pregnant or plan to become pregnant. It is not known whether DUPIXENT will harm your unborn baby.
- A pregnancy registry for women who take DUPIXENT during pregnancy collects information about the health of you and your baby.
- are breastfeeding or plan to breastfeed. It is not known whether DUPIXENT passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines or if you have CSU and asthma and use an asthma medicine. Do not change or stop your other medicines, including corticosteroid medicine or other asthma medicine, without talking to your healthcare provider. This may cause other symptoms that were controlled by those medicines to come back.
DUPIXENT can cause serious side effects, including:
- Allergic reactions. DUPIXENT can cause allergic reactions, including skin reactions, that can sometimes be severe. Stop using DUPIXENT and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms: breathing problems or wheezing, swelling of the face, lips, mouth, tongue, or throat, fainting, dizziness, feeling lightheaded, fast pulse, fever, hives, skin rash, including rash that looks like a bullseye, painful red or blue bumps under the skin, or red pus-filled spots on the skin, general ill feeling, itching, swollen lymph nodes, nausea or vomiting, joint pain, or cramps in your stomach area.
- Eye problems.Tell your healthcare provider right away if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision. Your healthcare provider may send you to an ophthalmologist for an eye exam if needed.
- Joint aches and pain. Some people who use DUPIXENT have had trouble walking or moving due to their joint symptoms, and in some cases needed to be hospitalized. Tell your healthcare provider about any new or worsening joint symptoms. Your healthcare provider may stop DUPIXENT if you develop joint symptoms.
The most common side effects in patients with chronic spontaneous urticaria includeinjection site reactions.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Use DUPIXENT exactly as prescribed by your healthcare provider. It's an injection given under the skin (subcutaneous injection). Your healthcare provider will decide if you or your caregiver can inject DUPIXENT. Do not try to prepare and inject DUPIXENT until you or your caregiver have been trained by your healthcare provider.
Please see accompanying fullPrescribing Information including Patient Information.
INDICATION
DUPIXENT is a prescription medicine used to treat adults and children 2 years of age and older with chronic spontaneous urticaria (CSU) who continue to have hives that are not controlled with H1 antihistamine treatment. DUPIXENT is not used to treat any other forms of hives (urticaria). It is not known if DUPIXENT is safe and effective in children with CSU under 2 years of age, or who weigh less than 11 pounds (5 kg).
US.DUP.26.09.0073 11/26
Source: BrandPoint











